Dr. Elan Mordeci Newman, MD

Dr. Newman practices at Sharp Rees-Stealy Medical Group, Inc in San Diego, California.

Dr. Newman's NPI, 1821297649, was assigned on July 12, 2007. Dr. Newman graduated from UC San Diego School of Medicine in 2006. Dr. Newman holds California license A100748.

Dr. Newman's primary practice is Sharp Rees-Stealy Medical Group, Inc, at 5651 Copley Dr, San Diego, CA 92111 in San Diego County. The practice phone is (858) 262-6666.

Dr. Newman's primary practice is Sharp Rees-Stealy Medical Group, Inc in San Diego, California. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Newman to 2 more group practices and clinics, 1 physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Newman practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Newman's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Newman is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Newman's licenses on file in 14 states: California, Arizona, Hawaii, Illinois, Nebraska, Ohio, Florida, Michigan, North Carolina, New Jersey, New York, Texas, Georgia and Pennsylvania.

Dmand AI lists benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, hives, itchy rashes, psoriasis, scalp rash and skin cyst among the conditions Dr. Newman treats.

CMS data shows 504 Medicare services from Dr. Newman across 8 procedure codes in 2024, for 165 Medicare patients. Medicare paid $25,070 for them. Every service was in an office.

CMS counts 165 Medicare patients who saw Dr. Newman in 2024. The largest group is 65 to 74, with 89 patients. 62% of them have high blood pressure, and 59% have high cholesterol. 8% are also on Medicaid. Their average risk score is 0.97, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Newman's median patient age at 57, with 57% women.

In 2024, Dr. Newman wrote 551 Medicare Part D claims for 173 patients. 86% of them were for generic drugs. CMS names the drug for 403 of them, across 15 drugs with 11 or more claims each, at $112,431 in total drug cost. In 2023, CMS named 291 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Newman for performance year 2024, reported as part of a group. Dr. Newman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 49 procedures of removal or shaving of skin growth by Dr. Newman, more than 79% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Newman in 2021. Dr. Newman's most frequent co-authors are Lawrence F. Eichenfield, MD, Michelle L. Jackson, MD and Fern P. Nelson, MD.

CMS Open Payments shows 281 general payments to Dr. Newman from 31 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 39% of the total. Allergan Inc. paid the most, $16,853.

Dr. Newman graduated from UC San Diego School of Medicine in 2006.

Dr. Newman is in network with 6 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.